Cargando…

PACAP Modulates the Autophagy Process in an In Vitro Model of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of complex etiology leading to motor neuron degeneration. Many gene alterations cause this pathology, including mutation in Cu, Zn superoxide dismutase (SOD1), which leads to its gain of function. Mutant SOD1 proteins are...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Amico, Agata Grazia, Maugeri, Grazia, Saccone, Salvatore, Federico, Concetta, Cavallaro, Sebastiano, Reglodi, Dora, D’Agata, Velia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216177/
https://www.ncbi.nlm.nih.gov/pubmed/32331311
http://dx.doi.org/10.3390/ijms21082943
_version_ 1783532358768525312
author D’Amico, Agata Grazia
Maugeri, Grazia
Saccone, Salvatore
Federico, Concetta
Cavallaro, Sebastiano
Reglodi, Dora
D’Agata, Velia
author_facet D’Amico, Agata Grazia
Maugeri, Grazia
Saccone, Salvatore
Federico, Concetta
Cavallaro, Sebastiano
Reglodi, Dora
D’Agata, Velia
author_sort D’Amico, Agata Grazia
collection PubMed
description Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of complex etiology leading to motor neuron degeneration. Many gene alterations cause this pathology, including mutation in Cu, Zn superoxide dismutase (SOD1), which leads to its gain of function. Mutant SOD1 proteins are prone to aberrant misfolding and create aggregates that impair autophagy. The hypoxic stress is strictly linked to the disease progression since it induces uncontrolled autophagy activation and the consequent high rates of cell death. Previously, we showed that pituitary adenylate cyclase-activating polypeptide (PACAP) exerts neurotrophic activity in cultured mSOD1 motor neurons exposed to serum deprivation. To date, no studies have examined whether the protective effect of PACAP on mSOD1 cells exposed to hypoxic insult is mediated through the regulation of the autophagy process. In the present study, we used the neuroblastoma-spinal cord-34 (NSC-34) cell line, stably expressing human wild type or mutant SOD1 G93A, to represent a well characterized in vitro model of a familial form of ALS. These cells were exposed to 100-µM desferrioxamine mesylate salt for 24h, to mimic the hypoxic stress affecting motor neurons during the disease progression. Our results showed that PACAP treatment significantly reduced cell death and hypoxia-induced mSOD1 accumulation by modulating the autophagy process in G93A motor neurons, as revealed by the decreased LC3II and the increased p62 levels, two autophagy indicators. These results were also confirmed by evaluating the vacuole formation detected through light chain 3 (LC3) immunofluorescence. Furthermore, the PACAP effects on autophagy seem to be mediated through the activation of the MAPK/ERK signaling pathway. Overall, our data demonstrated that PACAP exerts an ameliorative effect on the mSOD1 motor neuron viability by modulating a hypoxia-induced autophagy process through activation of MAPK/ERK signaling cascade.
format Online
Article
Text
id pubmed-7216177
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72161772020-05-22 PACAP Modulates the Autophagy Process in an In Vitro Model of Amyotrophic Lateral Sclerosis D’Amico, Agata Grazia Maugeri, Grazia Saccone, Salvatore Federico, Concetta Cavallaro, Sebastiano Reglodi, Dora D’Agata, Velia Int J Mol Sci Article Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of complex etiology leading to motor neuron degeneration. Many gene alterations cause this pathology, including mutation in Cu, Zn superoxide dismutase (SOD1), which leads to its gain of function. Mutant SOD1 proteins are prone to aberrant misfolding and create aggregates that impair autophagy. The hypoxic stress is strictly linked to the disease progression since it induces uncontrolled autophagy activation and the consequent high rates of cell death. Previously, we showed that pituitary adenylate cyclase-activating polypeptide (PACAP) exerts neurotrophic activity in cultured mSOD1 motor neurons exposed to serum deprivation. To date, no studies have examined whether the protective effect of PACAP on mSOD1 cells exposed to hypoxic insult is mediated through the regulation of the autophagy process. In the present study, we used the neuroblastoma-spinal cord-34 (NSC-34) cell line, stably expressing human wild type or mutant SOD1 G93A, to represent a well characterized in vitro model of a familial form of ALS. These cells were exposed to 100-µM desferrioxamine mesylate salt for 24h, to mimic the hypoxic stress affecting motor neurons during the disease progression. Our results showed that PACAP treatment significantly reduced cell death and hypoxia-induced mSOD1 accumulation by modulating the autophagy process in G93A motor neurons, as revealed by the decreased LC3II and the increased p62 levels, two autophagy indicators. These results were also confirmed by evaluating the vacuole formation detected through light chain 3 (LC3) immunofluorescence. Furthermore, the PACAP effects on autophagy seem to be mediated through the activation of the MAPK/ERK signaling pathway. Overall, our data demonstrated that PACAP exerts an ameliorative effect on the mSOD1 motor neuron viability by modulating a hypoxia-induced autophagy process through activation of MAPK/ERK signaling cascade. MDPI 2020-04-22 /pmc/articles/PMC7216177/ /pubmed/32331311 http://dx.doi.org/10.3390/ijms21082943 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
D’Amico, Agata Grazia
Maugeri, Grazia
Saccone, Salvatore
Federico, Concetta
Cavallaro, Sebastiano
Reglodi, Dora
D’Agata, Velia
PACAP Modulates the Autophagy Process in an In Vitro Model of Amyotrophic Lateral Sclerosis
title PACAP Modulates the Autophagy Process in an In Vitro Model of Amyotrophic Lateral Sclerosis
title_full PACAP Modulates the Autophagy Process in an In Vitro Model of Amyotrophic Lateral Sclerosis
title_fullStr PACAP Modulates the Autophagy Process in an In Vitro Model of Amyotrophic Lateral Sclerosis
title_full_unstemmed PACAP Modulates the Autophagy Process in an In Vitro Model of Amyotrophic Lateral Sclerosis
title_short PACAP Modulates the Autophagy Process in an In Vitro Model of Amyotrophic Lateral Sclerosis
title_sort pacap modulates the autophagy process in an in vitro model of amyotrophic lateral sclerosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216177/
https://www.ncbi.nlm.nih.gov/pubmed/32331311
http://dx.doi.org/10.3390/ijms21082943
work_keys_str_mv AT damicoagatagrazia pacapmodulatestheautophagyprocessinaninvitromodelofamyotrophiclateralsclerosis
AT maugerigrazia pacapmodulatestheautophagyprocessinaninvitromodelofamyotrophiclateralsclerosis
AT sacconesalvatore pacapmodulatestheautophagyprocessinaninvitromodelofamyotrophiclateralsclerosis
AT federicoconcetta pacapmodulatestheautophagyprocessinaninvitromodelofamyotrophiclateralsclerosis
AT cavallarosebastiano pacapmodulatestheautophagyprocessinaninvitromodelofamyotrophiclateralsclerosis
AT reglodidora pacapmodulatestheautophagyprocessinaninvitromodelofamyotrophiclateralsclerosis
AT dagatavelia pacapmodulatestheautophagyprocessinaninvitromodelofamyotrophiclateralsclerosis